TechTransfer and Ventures

October 2024 | Issue 12

At VCU, Collaborations Bring Ideas to Life

How does any university technology transfer program accelerate the pace of commercialization? Answer: You never work in a vacuum. 


This year, our team has focused on strengthening existing partnerships and building new ones both inside and outside of VCU. Internally, that means creating connections with centers and experts on all of our research and health system campuses. Beyond VCU, community connections help us find collaborators who may benefit from our deep bench of talent and our IP market — or investors willing to support but would otherwise be unaware of our offerings.

Collaborations improve our chances of accelerating the commercialization process and help us “bring ideas to life.”


Partnerships breed successes such as one of the biggest VCU has seen in recent years: the commercialization of Nerve Tape, invented by the School of Medicine hand surgeon Dr. Jonathan Isaacs and brought to market by the company licensee, BioCircuit Technologies. Nerve Tape is just as it sounds: a tape with tiny hooks that surgeons can use to connect spliced nerves back together. Achieving commercialization of a regulated product that must go through a rigorous FDA clearance process is a huge event for any university. But Dr. Isaacs and his partners did it and feedback from surgeons nationwide has been overwhelmingly positive. Nerve Tape is well on its way to becoming a critical tool for orthopaedic surgeons. We'll have more to share on Nerve Tape soon.


For now, read about some of our partnerships and inventors who are leading an innovation economy in Virginia.


Ivelina Metcheva, Ph.D., MBA

Assistant Vice President for Innovation

VCU TechTransfer and Ventures

Office of the Vice President for Research and Innovation

VCU team has designs on a game-changer in women's cancer treatment

Treatment of cervical and uterine cancers present significant challenges in radiation oncology. Navid Fallahi, M.D., a fourth-year clinical resident at the VCU School of Medicine, knew there had to be a better way.

Air Force awards $1.8M to VCU startup to advance development of drug treating massive blood loss

Perfusion Medical, a startup based off university IP, could soon launch a clinical trial to test an intravenous solution that its inventor, a School of Medicine physiologist and surgery professor, says can treat massive blood loss in trauma patients.

Biotech startup with VCU ties wins prestigious state grant for DNA analysis tool

Evizia, a startup with VCU roots, received a prestigious state grant to accelerate its work in advancing DNA analysis.

BioHealth Capital Region Forum Celebrates 10 years with Virginia, VCU TechTransfer and Ventures Leaders

Richmond startup based on VCU IP out to

improve cancer treatments

A spinout company from VCU Massey Comprehensive Cancer Center is developing targeted treatments for recurrent head and neck cancers, and other high burden skin disorders, using light-guided drug release to minimize side effects from the drug acting elsewhere. Read about them in Richmond Inno, part of the Business Journals network.

Four funds supporting research accepting applications

Four funds at the heart of VCU's wide-ranging research enterprise are accepting proposals in their latest cycle of funding.

VCU rises in new ranking of top public universities

The university moved up seven spots to tie for No. 69 in U.S. News & World Report’s annual ranking of top public universities.

Explore VCU inventions on the Technology Marketplace

VCU TechTransfer and Ventures | Visit our website

LinkedIn  Facebook